This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Grading the Dow Earnings; Reality Check, Anyone?: Jim Cramer's Best Blogs

4. Caterpillar (CAT - Get Report) gave you a performance that looks like the beginning of a multi-year turn because it was done without strong China, chiefly on the back of a better-than-expected business in the United States and huge cost takeouts. That buyback is fabulous. The stock's been too strong to get hammered here, as everyone, including many shorts, want to get in, not get out. That's something highly unusual during the Doug Oberhelman reign.

5. What can I say about Microsoft (MSFT) other than we would never have wanted Steve Ballmer's head if the company kept delivering this kind of quarter, with fabulous execution across everything from Windows to Surface to Enterprise and Xbox, where it was the real winner, by far, of the new console wars. Why is this stock still hanging in the high 30s? I can make a case for $40.

6. I am still reeling from how good United Technologies (UTX) was and how the business, like Honeywell (HON), got stronger and stronger as the quarter began. Untied Tech cited non-residential construction and aerospace as two industries that are gaining momentum and it singled out China as being particularly strong. The Chinese business is long cycle, long order and is gaining, thanks to Otis, not declining. Yet it had plummeted to $111 from $116, where buyers instantly emerged.

7. We have been waiting for a definitive turn in Procter & Gamble (PG) since A.G. Lafley came back and this was the quarter he did so. The organic growth, courtesy lots of new successful products, is kicking in. The emerging markets are gaining strength, even as the newfound weaker ones were actually addressed in a positive way. I can't believe that this stock has fallen to the high $70s and I wish our trust wasn't restricted because I want to do some buying.

Must Read: Diary of a Dividend Diva: D-Day Approaching

8. Did you catch Pfizer (PFE)? Did you see that growth after the patent cliff? This company is managing it far better than anyone thought and even though sales were weaker, there is no denying that the company has a very strong pipe and might, with a 3.5% yield, be one of the big bargains in the Dow.

Now, how about the Bs?

9. I know Goldman Sachs (GS) got hammered after it reported and that some have decided that this is the company that is most hobbled by the changes in Washington. I think that's just poppycock. Goldman's delivering good numbers and is set to deliver greater ones with the return of mergers and acquisitions to a higher level. It is just suffering by comparison to many of the other financials, but down to $163 from $179? How much lower can we expect this one to be hammered?

10. I know the perception is that GE (GE) really blew the quarter. But if you went over it line by line, you would find that aerospace and oil and gas were very good and healthcare was okay. The company is in reposition mode and it has tons of orders globally. It is suffering from a perceived downturn in China, but the facts don't bear it out. Yet it fell more than 10% from its high, a serious overreaction.

11. Verizon (VZ)? It was just your typical good Verizon quarter. The company can't shoot the lights out because it is just a GDP play to some degree, but the closing of the Verizon Wireless deal will give it some pep. A 4.5% yield in a 2.6% 10-year world? I would rather own Verizon at $47.

12,. Johnson & Johnson (JNJ) didn't deliver what I was looking for on the bottom line as the margins just weren't exceptional. But the top line was exceptional and that's what I want from a drug company. Lots in the pipe, a big payoff from the diagnostics sale and yet down to $88 from $95. Way over-punished for its B grade.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs